Parameswaran Hari

Chief Development Officer at Obsidian Therapeutics

Parameswaran Hari, M.D., M.S., is Obsidian’s Chief Development Officer. Dr. Hari brings decades of experience designing, managing and leading complex cell and gene therapy clinical programs, including TIL therapies. Previously, Dr. Hari was Senior Vice President, Clinical Science at Iovance Biotherapeutics, where he led solid tumor adoptive cell therapy programs across multiple tumor types and indications, including new IND submission, first in human phase 1 studies and BLA submission efforts. Prior to Iovance, Dr. Hari was the Chief of Hematology and Oncology at the Medical College of Wisconsin, where he led national cooperative multi-PI trial groups in cell and gene therapy and multiple myeloma. He also served the American Society of Transplantation and Cellular Therapy (ASTCT) as its secretary. Dr. Hari received his M.B.B.S at Kerala University, M.D. at Central University of Pondicherry, and his M.S. at the Medical College of Wisconsin.


Previous companies

Iovance Biotherapeutics logo
Medical College of Wisconsin logo


  • Chief Development Officer

    January, 2023 - present